Auris Medical Holding Ltd Share Price Nasdaq
Equities
BMG070251027
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.58M 2.88M 225M |
---|---|---|---|---|---|
Net income 2024 * | -7M -7.82M -612M | Net income 2025 * | -10M -11.17M -874M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.3
x | P/E ratio 2025 * |
-0.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.11% |
Latest transcript on Auris Medical Holding Ltd
Managers | Title | Age | Since |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 31/03/03 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 31/10/21 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 28/02/18 |
Mats Blom
BRD | Director/Board Member | 59 | 31/03/17 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 31/03/03 |
1st Jan change | Capi. | |
---|---|---|
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |